SYBLEU Inc
$0.06▲ 0.00%(+$0.00)
TickerSpark Score
46/100
▌ Weak
47
Valuation
60
Profitability
55
Growth
40
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SYBE research report →
52-Week Range100% of range
Low
$0.04
Current
$0.06
High
$0.06
Company Overviewwww.sybleu.com
About the company
Established in 2020, SYBLEU Inc. specializes in developing regenerative medical applications. The firm's headquarters are located in Bronx, New York.
- CEO
- Joseph G. Vaini
- IPO
- 2023
- Employees
- 2
- HQ
- Bronx, NY, US
Price Chart
+0.00% · this period
Valuation
- Market Cap
- $583.74K
- P/E
- -3.14
- P/S
- 49.91
- P/B
- -2.14
- EV/EBITDA
- -4.85
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -1275.48%
- Net Margin
- -1541.59%
- ROE
- 69.88%
- ROIC
- -501.99%
Growth & Income
- Revenue
- $11.70K · -0.03%
- Net Income
- $-180,304 · 26.51%
- EPS
- $-0.02 · 24.24%
- Op Income
- $-149,180
- FCF YoY
- -28.06%
Performance & Tape
- 52W High
- $0.06
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.06
- Beta
- 1.63
- Avg Volume
- 2.90K
Get TickerSpark's AI analysis on SYBE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · SYBE
Our SYBE coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on SYBE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SYBE report →Internal Compare
Similar companies
Peers in the same neighborhood.